Modulation of Ca2+ Signaling by Anti-apoptotic B-Cell Lymphoma 2 Proteins at the Endoplasmic Reticulum–Mitochondrial Interface
暂无分享,去创建一个
[1] J. Parys,et al. The selective Bcl-2 inhibitor venetoclax, a BH3 mimetic, does not dysregulate intracellular Ca2+ signaling. , 2017, Biochimica et biophysica acta. Molecular cell research.
[2] Ye Xu,et al. ABT737 reverses cisplatin resistance by regulating ER-mitochondria Ca2+ signal transduction in human ovarian cancer cells. , 2016, International journal of oncology.
[3] A. Strasser,et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models , 2016, Nature.
[4] J. Parys,et al. Bcl-2 proteins and calcium signaling: complexity beneath the surface , 2016, Oncogene.
[5] J. Parys,et al. The trans-membrane domain of Bcl-2α, but not its hydrophobic cleft, is a critical determinant for efficient IP3 receptor inhibition , 2016, Oncotarget.
[6] D. Green. A BH3 Mimetic for Killing Cancer Cells , 2016, Cell.
[7] P. Pinton,et al. ER functions of oncogenes and tumor suppressors: Modulators of intracellular Ca(2+) signaling. , 2016, Biochimica et biophysica acta.
[8] M. Hoth. CRAC channels, calcium, and cancer in light of the driver and passenger concept. , 2016, Biochimica et biophysica acta.
[9] Rita Padányi,et al. Multifaceted plasma membrane Ca(2+) pumps: From structure to intracellular Ca(2+) handling and cancer. , 2016, Biochimica et biophysica acta.
[10] R. Rao,et al. Calcium-ATPases: Gene disorders and dysregulation in cancer. , 2016, Biochimica et biophysica acta.
[11] Na Ye,et al. BH4 domain of Bcl-2 as a novel target for cancer therapy. , 2016, Drug discovery today.
[12] J. Foskett,et al. InsP3R, the calcium whisperer: Maintaining mitochondrial function in cancer , 2016, Molecular & cellular oncology.
[13] M. Betenbaugh,et al. The non-apoptotic action of Bcl-xL: regulating Ca2+ signaling and bioenergetics at the ER-mitochondrion interface , 2016, Journal of Bioenergetics and Biomembranes.
[14] G. Bultynck. Onco-IP3Rs Feed Cancerous Cravings for Mitochondrial Ca(2.). , 2016, Trends in biochemical sciences.
[15] S. Lonial,et al. BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth , 2016, Oncotarget.
[16] J. Diehl,et al. Selective Vulnerability of Cancer Cells by Inhibition of Ca(2+) Transfer from Endoplasmic Reticulum to Mitochondria. , 2016, Cell reports.
[17] J. Foskett,et al. Biphasic regulation of InsP3 receptor gating by dual Ca2+ release channel BH3-like domains mediates Bcl-xL control of cell viability , 2016, Proceedings of the National Academy of Sciences.
[18] P. Pinton,et al. Mcl-1 involvement in mitochondrial dynamics is associated with apoptotic cell death , 2016, Molecular biology of the cell.
[19] G. Wildey,et al. Synergistic killing of human small cell lung cancer cells by the Bcl-2-inositol 1,4,5-trisphosphate receptor disruptor BIRD-2 and the BH3-mimetic ABT-263 , 2015, Cell Death and Disease.
[20] G. Bultynck,et al. Antagonizing Bcl-2′s BH4 domain in cancer , 2015, Aging.
[21] V. Shoshan-Barmatz,et al. The mitochondrial voltage-dependent anion channel 1 in tumor cells. , 2015, Biochimica et biophysica acta.
[22] P. Pinton,et al. Novel frontiers in calcium signaling: A possible target for chemotherapy. , 2015, Pharmacological research.
[23] J. Pink,et al. A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2 , 2015, Oncotarget.
[24] Guangyi Wang,et al. ABT737 enhances cholangiocarcinoma sensitivity to cisplatin through regulation of mitochondrial dynamics. , 2015, Experimental cell research.
[25] Á. Almeida,et al. Regulation of Bcl-xL–ATP Synthase Interaction by Mitochondrial Cyclin B1–Cyclin-Dependent Kinase-1 Determines Neuronal Survival , 2015, The Journal of Neuroscience.
[26] W. Curran,et al. Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy. , 2015, Cancer cell.
[27] P. Pinton,et al. Mitochondria-associated membranes: composition, molecular mechanisms, and physiopathological implications. , 2015, Antioxidants & redox signaling.
[28] G. Bultynck,et al. p53 and Ca2+ signaling from the endoplasmic reticulum: partners in anti-cancer therapies , 2015, Oncoscience.
[29] L. Walensky,et al. Inhibition of Pro-apoptotic BAX by a noncanonical interaction mechanism. , 2015, Molecular cell.
[30] P. Agostinis,et al. The BH4 Domain of Anti-apoptotic Bcl-XL, but Not That of the Related Bcl-2, Limits the Voltage-dependent Anion Channel 1 (VDAC1)-mediated Transfer of Pro-apoptotic Ca2+ Signals to Mitochondria* , 2015, The Journal of Biological Chemistry.
[31] G. Hankins,et al. The BRCA1 Tumor Suppressor Binds to Inositol 1,4,5-Trisphosphate Receptors to Stimulate Apoptotic Calcium Release* , 2015, The Journal of Biological Chemistry.
[32] F. Mammano,et al. p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+-dependent manner , 2015, Proceedings of the National Academy of Sciences.
[33] F. Mammano,et al. Intravital imaging reveals p53-dependent cancer cell death induced by phototherapy via calcium signaling , 2014, Oncotarget.
[34] N. Bradbury,et al. Mcl-1 promotes lung cancer cell migration by directly interacting with VDAC to increase mitochondrial Ca2+ uptake and reactive oxygen species generation , 2014, Cell Death and Disease.
[35] M. Benahmed,et al. Remodeling of channel-forming ORAI proteins determines an oncogenic switch in prostate cancer. , 2014, Cancer cell.
[36] S. Grimm,et al. Mitochondrial Ca2+ influx targets cardiolipin to disintegrate respiratory chain complex II for cell death induction , 2014, Cell Death and Differentiation.
[37] M. Betenbaugh,et al. Bcl-2 family in inter-organelle modulation of calcium signaling; roles in bioenergetics and cell survival , 2014, Journal of Bioenergetics and Biomembranes.
[38] Chi Li,et al. An Interaction between Bcl-xL and the Voltage-dependent Anion Channel (VDAC) Promotes Mitochondrial Ca2+ Uptake* , 2013, The Journal of Biological Chemistry.
[39] K. Mikoshiba,et al. IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2 , 2013, Cell Death and Disease.
[40] G. Bultynck,et al. Altered Ca(2+) signaling in cancer cells: proto-oncogenes and tumor suppressors targeting IP3 receptors. , 2013, Biochimica et biophysica acta.
[41] G. Bultynck,et al. The selective BH4-domain biology of Bcl-2-family members: IP3Rs and beyond , 2013, Cellular and Molecular Life Sciences.
[42] V. Giorgio,et al. Dimers of mitochondrial ATP synthase form the permeability transition pore , 2013, Proceedings of the National Academy of Sciences.
[43] John M. Ashton,et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. , 2013, Cell stem cell.
[44] L. Galluzzi,et al. Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition , 2013, Cell cycle.
[45] L. Lam,et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets , 2013, Nature Medicine.
[46] L. Missiaen,et al. Profiling of the Bcl-2/Bcl-X(L)-binding sites on type 1 IP(3) receptor. , 2012, Biochemical and biophysical research communications.
[47] A. Letai,et al. Targeting the B-cell lymphoma/leukemia 2 family in cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] Rosario Rizzuto,et al. Mitochondria as sensors and regulators of calcium signalling , 2012, Nature Reviews Molecular Cell Biology.
[49] F. Davis,et al. Calcium Channels and Pumps in Cancer: Changes and Consequences* , 2012, The Journal of Biological Chemistry.
[50] V. Shoshan-Barmatz,et al. Mediation of the Antiapoptotic Activity of Bcl-xL Protein upon Interaction with VDAC1 Protein* , 2012, The Journal of Biological Chemistry.
[51] Daniel P. Stewart,et al. Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration , 2012, Nature Cell Biology.
[52] R. Balaban,et al. Role of mitochondrial Ca2+ in the regulation of cellular energetics. , 2012, Biochemistry.
[53] S. Grimm. The ER-mitochondria interface: the social network of cell death. , 2012, Biochimica et biophysica acta.
[54] L. Kaczmarek,et al. Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential , 2011, The Journal of cell biology.
[55] M. Bootman,et al. Bcl-2 interaction with the inositol 1,4,5-trisphosphate receptor: role in Ca(2+) signaling and disease. , 2011, Cell calcium.
[56] A. Roberts,et al. Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets. , 2011, Blood.
[57] M. de Maeyer,et al. Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl , 2011, Cell Death and Differentiation.
[58] Shanta M. Messerli,et al. Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase , 2011, Nature Cell Biology.
[59] Peifang Liu,et al. Functional SNP in the microRNA-367 binding site in the 3′UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification , 2011, Proceedings of the National Academy of Sciences.
[60] N. Prevarskaya,et al. Calcium in tumour metastasis: new roles for known actors , 2011, Nature Reviews Cancer.
[61] I. Ambudkar,et al. Faculty Opinions recommendation of A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. , 2011 .
[62] V. Mootha,et al. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter , 2011, Nature.
[63] P. Pinton,et al. Mitochondria associated membranes (MAMs) as critical hubs for apoptosis , 2011, Communicative & Integrative Biology.
[64] J. Parys,et al. Induction of Ca²+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interaction. , 2011, Blood.
[65] D. Green,et al. Apoptosis and oncogenesis: give and take in the BCL-2 family. , 2011, Current opinion in genetics & development.
[66] P. Kenny,et al. ORAI1-Mediated Calcium Influx in Lactation and in Breast Cancer , 2011, Molecular Cancer Therapeutics.
[67] C. Distelhorst,et al. Apoptosis and autophagy: decoding calcium signals that mediate life or death. , 2010, Cold Spring Harbor perspectives in biology.
[68] M. Birnbaum,et al. Essential Regulation of Cell Bioenergetics by Constitutive InsP3 Receptor Ca2+ Transfer to Mitochondria , 2010, Cell.
[69] D. Andrews,et al. Bcl-2 and Bax Interact via the BH1–3 Groove-BH3 Motif Interface and a Novel Interface Involving the BH4 Motif* , 2010, The Journal of Biological Chemistry.
[70] V. De Pinto,et al. VDAC, a multi-functional mitochondrial protein regulating cell life and death. , 2010, Molecular aspects of medicine.
[71] J. Foskett,et al. Apoptosis Protection by Mcl-1 and Bcl-2 Modulation of Inositol 1,4,5-Trisphosphate Receptor-dependent Ca2+ Signaling* , 2010, The Journal of Biological Chemistry.
[72] D. Green,et al. The BCL-2 family reunion. , 2010, Molecular cell.
[73] Derek Y. Chiang,et al. The landscape of somatic copy-number alteration across human cancers , 2010, Nature.
[74] V. Shoshan-Barmatz,et al. Voltage-dependent Anion Channel 1-based Peptides Interact with Bcl-2 to Prevent Antiapoptotic Activity* , 2009, The Journal of Biological Chemistry.
[75] M. Bootman,et al. The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor , 2009, Proceedings of the National Academy of Sciences.
[76] P. M. Hwang,et al. The Krebs cycle meets the cell cycle: Mitochondria and the G1–S transition , 2009, Proceedings of the National Academy of Sciences.
[77] V. Yee,et al. Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor. , 2009, Biochimica et biophysica acta.
[78] V. Shoshan-Barmatz,et al. The VDAC1 N-terminus is essential both for apoptosis and the protective effect of anti-apoptotic proteins , 2009, Journal of Cell Science.
[79] A. Letai,et al. Control of mitochondrial apoptosis by the Bcl-2 family , 2009, Journal of Cell Science.
[80] J. Foskett,et al. Bcl-xL Regulation of InsP3 Receptor Gating Mediated by Dual Ca2+ Release Channel BH3 Domains , 2009 .
[81] John Calvin Reed,et al. Bcl-2 family proteins and cancer , 2008, Oncogene.
[82] M. Berridge,et al. The versatility and complexity of calcium signalling. , 2008, Novartis Foundation symposium.
[83] M. Bootman,et al. Bcl-2 suppresses Ca2+ release through inositol 1,4,5-trisphosphate receptors and inhibits Ca2+ uptake by mitochondria without affecting ER calcium store content. , 2008, Cell calcium.
[84] Xiang Li,et al. Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals. , 2008, Molecular cell.
[85] H. Llewelyn Roderick,et al. Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival , 2008, Nature Reviews Cancer.
[86] Sarah J. Roberts-Thomson,et al. Calcium and cancer: targeting Ca2+ transport , 2007, Nature Reviews Cancer.
[87] P. Várnai,et al. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels , 2006, The Journal of cell biology.
[88] F. Zhong,et al. Bcl-2 differentially regulates Ca2+ signals according to the strength of T cell receptor activation , 2006, The Journal of cell biology.
[89] C. Thompson,et al. The endoplasmic reticulum gateway to apoptosis by Bcl-XL modulation of the InsP3R , 2005, Nature Cell Biology.
[90] S. Korsmeyer,et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.
[91] M. Berridge,et al. Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate , 2004, The Journal of cell biology.
[92] G. Shore,et al. Bcl-2 and calcium: controversy beneath the surface , 2004, Oncogene.
[93] Masashi Narita,et al. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC , 1999, Nature.
[94] J. Parys,et al. Inositol 1,4,5-trisphosphate and its receptors. , 2012, Advances in experimental medicine and biology.